Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

NUCLEAR SIGNALING BY INTERLEUKIN-6 CURRENT OPINION IN IMMUNOLOGY CHENKIANG, S., Hsu, W., Natkunam, Y., Zhang, X. K. 1993; 5 (1): 124-128

Abstract

The molecular analysis of the regulation of nuclear proteins induced by interleukin-6 has provided new insights into this largely unknown signal transduction pathway. Transcription factors of the CCAAT/enhancer-binding protein and AP-1 families, as well as the octamer-binding proteins and the tumor suppressor gene product pRB, are regulated by interleukin-6 in a cell type specific manner, suggesting that they may play a role in the nuclear signaling by interleukin-6.

View details for Web of Science ID A1993KN29300020

View details for PubMedID 8452668